- Home
- NFBK vs TLRY Comparison
NFBK vs TLRY Comparison
Compare NFBK & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NFBK | TLRY |
|---|---|---|
| Founded | 1887 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 607.7M | 570.4M |
| IPO Year | 2010 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NFBK | TLRY |
|---|---|---|
| Price | $15.44 | $3.88 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $13.50 | ★ $72.33 |
| AVG Volume (30 Days) | 407.4K | ★ 3.5M |
| Earning Date | 04-20-2026 | 04-01-2026 |
| Dividend Yield | ★ 3.73% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $6,870,000.00 | N/A |
| Revenue This Year | $4.95 | $8.79 |
| Revenue Next Year | $6.32 | $19.98 |
| P/E Ratio | $51.47 | ★ N/A |
| Revenue Growth | ★ 6.84 | N/A |
| 52 Week Low | $9.91 | $0.55 |
| 52 Week High | $15.61 | $15.70 |
Technical Indicators
Market Signals| Indicator | NFBK | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 69.24 | 22.50 |
| Support Level | $14.25 | $0.77 |
| Resistance Level | N/A | $4.85 |
| Average True Range (ATR) | 0.30 | 0.18 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 86.08 | 3.18 |
Price Performance
Historical ComparisonAbout NFBK Northfield Bancorp Inc. (Delaware)
Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union, and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.